A case of multidrug-resistant Salmonella enterica serovar typhi treated with a bench to bedside approach

Yonsei Medical Journal

Volumn 50, Issue 1, 2009, Pages 147-151

  Yoon, Hee Jung ^a   Cho, Soung Hoon ^a   Kim, Seong Han ^b  

^a Eulji University   (South Korea)

^b Korea National Institute of Health   (South Korea)

Author keywords

Multi drug resistance; Salmonella enterica serovar Typhi; Treatment

Indexed keywords

AMIKACIN; AMPICILLIN; AZTREONAM; BETA LACTAMASE TEM 1; CEFAZOLIN; CEFEPIME; CEFOXITIN; CEFTRIAXONE; CIPROFLOXACIN; COTRIMOXAZOLE; DNA TOPOISOMERASE (ATP HYDROLYSING) A; EXTENDED SPECTRUM BETA LACTAMASE; GENTAMICIN; IMIPENEM; MEROPENEM; NALIDIXIC ACID; PIPERACILLIN PLUS TAZOBACTAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SULBACTAM; SULTAMICILLIN; TOBRAMYCIN;

ABDOMINAL TENDERNESS; ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTEREMIA; BACTERIAL MUTATION; BLOOD CULTURE; CASE REPORT; DIARRHEA; DRUG TREATMENT FAILURE; ENZYME ANALYSIS; FEVER; HUMAN; INDIA; LABORATORY TEST; MALE; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; NONHUMAN; PHYSICAL EXAMINATION; SALMONELLA TYPHI; SEROTYPE; TONSILLITIS; TRAVEL;

ADULT; ANTI-BACTERIAL AGENTS; AZTREONAM; BACTEREMIA; DRUG RESISTANCE, BACTERIAL; DRUG RESISTANCE, MULTIPLE; DRUG THERAPY, COMBINATION; HUMANS; MALE; SALMONELLA TYPHI; THIENAMYCINS; TYPHOID FEVER;

EID: 62749182341     PISSN: 05135796     EISSN: None     Source Type: Journal    
DOI: 10.3349/ymj.2009.50.1.147     Document Type: Article

References (27)

1. Edelman R, Levine MM. Summary of an international workshop on typhoid fever. Rev Infect Dis 1986;8:329-49.
2. Giraud E, Brisabois A, Martel JL, Chaslus-Dancla E. Comparative studies of mutations in animal isolates and experimental in vitro- and in vivo-selected mutants of Salmonella spp. suggest a counterselection of highly fluoroquinolone-resistant strains in the field. Antimicrob Agents Chemother 1999;43:2131-7.
3. Bhutta ZA. Current concepts in the diagnosis and treatment of typhoid fever. BMJ 2006;333:78-82.
4. Olarte J, Galindo E. Salmonella typhi resistant to chloramphenicol, ampicillin, and other antimicrobial agents: strains isolated during an extensive typhoid fever epidemic in Mexico. Antimicrob Agents Chemother 1973; 4:597-601.
5. Brown JD, Duong Hong M, Rhodes ER. Chloramphenicol-resistant Salmonella typhi in Saigon. JAMA 1975; 231:162-6.
6. Lee K, Yong D, Yum JH, Lim YS, Chong Y, Lee BK. Abstract. 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy, Abstract C2-865, 2003.
7. Lee K, Yong D, Yum JH, Lim YS, Kim HS, Lee BK, et al. Emergence of multidrug-resistant Salmonella enterica serovar Typhi in Korea. Antimicrob Agents Chemother 2004;48:4130-5.
8. Shin YH, Yoo JS, Kim KS, Chung DJ, Oh KS, Lee JK, et al. In vitro antimicrobial susceptibility of Salmonella typhi, Salmonella typhimurium andSalmonella enteritidis isolated in Korea, 1997. J Korean Soc Chemother 1998; 16:205-14.
9. Hanson ND, Thomson KS, Moland ES, Sanders CC, Berthold G, Penn RG. Molecular characterization of a multiply resistant Klebsiella pneumoniae encoding ESBLs and a plasmid-mediated AmpC. J Antimicrob Chemother 1999;44:377-80.
10. Rasheed JK, Jay C, Metchock B, Berkowitz F, Weigel L, Crellin J, et al. Evolution of extended-spectrum β-lactam resistance (SHV-8) in a strain of Escherichia coli during multiple episodes of bacteremia. Antimicrob Agents Chemother 1997;41:647-53.
11. Pitout JD, Hossain A, Hanson ND. Phenotypic and molecular detection of CTX-M-β-lactamases produced by Escherichia coli and Klebsiella spp. J Clin Microbiol 2004;42:5715-21.
12. Pérez-Pérez FJ, Hanson ND. Detection of plasmid-mediated AmpC β-lactamase genes in clinical isolates by using multiplex PCR. J Clin Microbiol 2002;40:2153-62.
13. Gupta B, Kumar R, Khurana S. Multi drug resistant Salmonella Typhi in Ludhiana (Punjab). Indian J Pathol Microbiol 1993;36:5-7.
14. Gautam V, Gupta NK, Chaudhary U, Arora DR. Sensitivity pattern of Salmonella serotypes in Northern India. Braz J Infect Dis 2002;6:281-7.
15. Jones RN, Rhomberg PR, Varnam DJ, Mathai D. A comparison of the antimicrobial activity of meropenem and selected broad-spectrum antimicrobials tested against multi-drug resistant Gram-negative bacilli including bacteraemic Salmonella spp.: initial studies for the MYSTIC programme in India. Int J Antimicrob Agents 2002;20:426-31.
16. Pokharel BM, Koirala J, Dahal RK, Mishra SK, Khadga PK, Tuladhar NR. Multidrug-resistant and extended-spectrum beta-lactamase (ESBL)-producing Salmonella enterica (serotypes Typhi and Paratyphi A) from blood isolates in Nepal: surveillance of resistance and a search for newer alternatives. Int J Infect Dis 2006;10: 434-8.
17. Jean SS, Lee YT, Guo SM, Hsueh PR. Recurrent infections caused by cefotaxime- and ciprofloxacin-resistant Salmonella enterica serotype choleraesuis teated successfully with imipenem. J Infect 2005;51:e163-5.
18. Mathai D, Rhomberg PR, Biedenbach DJ, Jones RN; The India Antimicrobial Resistance Study Group. Evaluation of the in vitro activity of six broad-spectrum β-lactam antimicrobial agents tested against recent clinical isolates from India: a survey of ten medical center laboratories. Diagn Microbiol Infect Dis 2002;44: 367-77.
19. Piddock LJ, Johnson MM, Webber MA. Activity of faropenem and imipenem for ciprofloxacin-resistant bacteria. J Antimicrob Chemother 2003;52:500-2.
20. Adinolfi LE, Utili R, Dilillo M, Tripodi MF, Attanasio V, Ruggiero G. Intracellular activity of cefamandole and aztreonam against phagocytosed Escherichia coli and Staphylococcus aureus. J Antimicrob Chemother 1989; 24:927-35.
21. Pruul H, Lewis G, McDonald PJ. Enhanced susceptibility of gram-negative bacteria to phagocytic killing by human polymorphonuclear leucocytes after brief exposure to aztreonam. J Antimicrob Chemother 1998;22: 675-86.
22. Bonina L, Carbone M, Matera G, Teti G, Joysey HS, Hormaeche CE, et al. Beta-lactam antibiotics (aztreonam, ampicillin, cefazolin and ceftazidime) in the control and eradication of Salmonella typhimurium in naturally resistant and susceptible mice. J Antimicrob Chemother 1990;25:813-23.
23. Gotuzzo E, Echevarría J, Carrillo C, Sánchez J, Grados P, Maguiña C, et al. Randomized comparison of aztreonam and chloramphenicol in treatment of typhoid fever. Antimicrob Agents Chemother 1994;38:558-62.
24. Paradelis AG, Delidou K, Stavrakis AO, Crassaris LG. Comparative in vitro activity of aztreonam and other antimicrobial agents against Salmonella species. Drugs Exp Clin Res 1985;11:163-7.
25. Girgis NI, Sultan Y, Hammad O, Farid Z. Comparison of the efficacy, safety and cost of cefixime, ceftriaxone and aztreonam in the treatment of multidrug-resistant Salmonella typhi septicemia in children. Pediatr Infect Dis J 1995;14:603-5.
26. Hooper DC. Mechanisms of fluoroquinolone resistance. Drug Resist Updat 1999;2:38-55.
27. Paterson DL. Resistance in gram-negative bacteria: enterrobacteriaceae. Am J Med 2006;119(6 Suppl 1):S20-8; discussion S62-70.